Moody Lynn & Lieberson LLC Sells 1,520 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Moody Lynn & Lieberson LLC reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 16.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 7,895 shares of the biotechnology company’s stock after selling 1,520 shares during the period. Moody Lynn & Lieberson LLC’s holdings in Axon Enterprise were worth $4,692,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Jacksonville Wealth Management LLC purchased a new position in shares of Axon Enterprise during the fourth quarter worth approximately $2,904,000. Linden Thomas Advisory Services LLC grew its holdings in shares of Axon Enterprise by 20.5% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 910 shares of the biotechnology company’s stock valued at $541,000 after purchasing an additional 155 shares during the last quarter. Geneos Wealth Management Inc. raised its position in Axon Enterprise by 630.0% in the 4th quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company’s stock worth $1,098,000 after purchasing an additional 1,594 shares during the period. Dynamic Advisor Solutions LLC lifted its stake in Axon Enterprise by 35.6% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 3,246 shares of the biotechnology company’s stock worth $1,929,000 after purchasing an additional 852 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. boosted its position in Axon Enterprise by 56.2% during the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 5,867 shares of the biotechnology company’s stock valued at $3,487,000 after buying an additional 2,111 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

Axon Enterprise Trading Down 0.5 %

NASDAQ:AXON opened at $610.32 on Friday. The stock has a market cap of $46.54 billion, a price-to-earnings ratio of 157.71, a PEG ratio of 6.09 and a beta of 1.04. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average price is $617.65 and its 200-day moving average price is $470.75. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.